The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schountz, T.
Right arrow Articles by Murray, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schountz, T.
Right arrow Articles by Murray, J. S.

The Journal of Immunology, Vol 157, Issue 9 3893-3901, Copyright © 1996 by American Association of Immunologists

ARTICLES

MHC genotype controls the capacity of ligand density to switch T helper (Th)-1/Th-2 priming in vivo

T Schountz, JP Kasselman, FA Martinson, L Brown and JS Murray
Center for Basic Cancer Research, Kansas State University, Manhattan 66506, USA.

A quantitative mechanism for the differentiation of CD4 T cells into recognized subsets of Th1 and Th2 effectors is controversial. Here, we define the Ag dose more precisely to the density of a minimal immunogenic peptide presented on the surface of a specific APC type. Th1 and Th2 responder MHC genotypes differ by as much as an order of magnitude in the density of this peptide displayed on B7-2+ B cells. We asked whether such B cells presenting a low ligand density primed Th2 effectors in an MHC genotype with predisposed high-density presentation and Th1-type immunity, and whether high ligand density B cells primed Th1 effectors in an MHC genotype that normally presents a low density and the Th2 phenotype. While low ligand density had the capacity to switch phenotype in the Th1 responder, high-density presentation did not alter genetically determined Th2 responder status.


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Schountz, J. Prescott, A. C. Cogswell, L. Oko, K. Mirowsky-Garcia, A. P. Galvez, and B. Hjelle
Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus
PNAS, September 25, 2007; 104(39): 15496 - 15501.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. A. Ascon, J. Ochoa-Reparaz, N. Walters, and D. W. Pascual
Partially Assembled K99 Fimbriae Are Required for Protection
Infect. Immun., November 1, 2005; 73(11): 7274 - 7280.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
A. L.-D. de Cerio, J. J. Lasarte, N. Casares, P. Sarobe, M. Ruiz, J. Prieto, and F. Borras-Cuesta
Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responses
Int. Immunol., June 1, 2003; 15(6): 691 - 699.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Dimitrova, A. Skapenko, M. L. Herrmann, R. Schleyerbach, J. R. Kalden, and H. Schulze-Koops
Restriction of De Novo Pyrimidine Biosynthesis Inhibits Th1 Cell Activation and Promotes Th2 Cell Differentiation
J. Immunol., September 15, 2002; 169(6): 3392 - 3399.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
G. Malcolm Taylor, S. Dearden, P. Ravetto, M. Ayres, P. Watson, A. Hussain, M. Greaves, F. Alexander, O. B. Eden, and UKCCS Investigators
Genetic susceptibility to childhood common acute lymphoblastic leukaemia is associated with polymorphic peptide-binding pocket profiles in HLA-DPB1*0201
Hum. Mol. Genet., July 1, 2002; 11(14): 1585 - 1597.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S. Saarelainen, T. Zeiler, J. Rautiainen, A. Narvanen, M. Rytkonen-Nissinen, R. Mantyjarvi, P. Vilja, and T. Virtanen
Lipocalin allergen Bos d 2 is a weak immunogen
Int. Immunol., April 1, 2002; 14(4): 401 - 409.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
R. D. J. Huby, R. J. Dearman, and I. Kimber
Why Are Some Proteins Allergens?
Toxicol. Sci., June 1, 2000; 55(2): 235 - 246.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Todt, J. Sonstein, T. Polak, G. D. Seitzman, B. Hu, and J. L. Curtis
Repeated Intratracheal Challenge with Particulate Antigen Modulates Murine Lung Cytokines ,2
J. Immunol., April 15, 2000; 164(8): 4037 - 4047.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. R. Rogers and M. Croft
CD28, Ox-40, LFA-1, and CD4 Modulation of Th1/Th2 Differentiation Is Directly Dependent on the Dose of Antigen
J. Immunol., March 15, 2000; 164(6): 2955 - 2963.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. R. Rogers and M. Croft
Peptide Dose, Affinity, and Time of Differentiation Can Contribute to the Th1/Th2 Cytokine Balance
J. Immunol., August 1, 1999; 163(3): 1205 - 1213.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. G. von Herrath, B. Coon, H. Lewicki, H. Mazarguil, J. E. Gairin, and M. B. A. Oldstone
In Vivo Treatment with a MHC Class I-Restricted Blocking Peptide Can Prevent Virus-Induced Autoimmune Diabetes
J. Immunol., November 1, 1998; 161(9): 5087 - 5096.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Chen and D. L. Boros
Identification of the Immunodominant T Cell Epitope of p38, a Major Egg Antigen, and Characterization of the Epitope-Specific Th Responsiveness During Murine Schistosomiasis Mansoni
J. Immunol., June 1, 1998; 160(11): 5420 - 5427.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.